Summary & Overview
CPT 11000: Surgical Debridement of Skin, Up to 10% Body Surface
CPT code 11000 denotes surgical debridement of necrotic skin tissue for up to 10% of the body surface. It captures a common, focused surgical intervention used to remove dead skin and reduce infection risk in wounds, burns, and other dermatologic or traumatic injuries. As an elementary procedural CPT code, 11000 is important for accurate clinical documentation, proper claim adjudication, and national utilization tracking of minor debridement procedures.
Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose and typical settings for this procedure, the common modifiers associated with billing for procedural nuances, and reference points for related service lines. The publication outlines the clinical context in which CPT code 11000 is used, typical sites of service such as ambulatory surgical centers and hospital outpatient departments, and the role of precise coding in ensuring appropriate coverage determinations. Data on payer-specific policies, utilization benchmarks, and associated diagnosis code mappings are not provided in the input. Data not available in the input.
Billing Code Overview
CPT code 11000 describes surgical debridement of necrotic (dead) tissue of the skin, limited to up to 10 percent of the body surface. This procedure involves the use of surgical instruments to remove devitalized tissue to promote wound healing and reduce infection risk.
-
Service type: Surgical debridement, limited superficial skin debridement
-
Typical site of service: Ambulatory surgical center, hospital outpatient department, or other settings where minor surgical skin procedures are performed
Clinical & Coding Specifications
Clinical Context
A 67-year-old male with peripheral vascular disease and type 2 diabetes presents to the outpatient wound clinic with an infected, necrotic area of necrosis on the lower leg covering approximately 6% of body surface area. The wound has nonviable devitalized tissue producing exudate and odor. The surgeon obtains informed consent, evaluates vascular status, and documents the total body surface area involved (under 10%). In the minor procedure suite, under local anesthesia and sterile conditions, the provider uses scalpels, curettes, and forceps to surgically remove devitalized tissue (sharp debridement) until viable tissue and bleeding margins are encountered. Hemostasis is achieved, wound bed is irrigated, and dressing applied. Post-procedure documentation includes extent of debridement, measurements, anesthesia, any complications, and plan for re-evaluation and possible adjunctive therapies (topical antimicrobials, offloading, vascular referral). Typical sites of service: outpatient wound clinic, ambulatory surgical center, emergency department, or inpatient bedside procedure when required by patient acuity.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than usual for 11000 and documentation supports additional complexity. |